Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Software for Malvern’s NanoSight NTA Systems

Published: Friday, July 18, 2014
Last Updated: Thursday, July 17, 2014
Bookmark and Share
NTA 3.0 from Malvern improves user experience and enhances performance.

Malvern Instruments has launched NTA 3.0, a new version of the software that drives its NanoSight Nanoparticle Tracking Analysis (NTA) systems. With an improved, easy-to-use interface, the new NTA 3.0 software makes accessing programs and protocols quick and convenient.

It also incorporates an upgraded high-resolution particle size distribution algorithm, and supports advanced image analysis, particle detection and tracking, as well as providing improved vibration correction.

The new software is designed for use across the complete NanoSight NTA range and will be integral to all new systems shipped, while existing users can download their free upgrade via the appropriate product page on the Malvern website:

• NanoSight NS300 www.malvern.com/ns300sw
• NanoSight LM10 www.malvern.com/lm10sw
• NanoSight NS500 www.malvern.com/ns500sw

Malvern NanoSight systems use Nanoparticle Tracking Analysis (NTA) to characterize nanoparticles in solution in the size range 10 nm to 2000 nm (depending on the sample). Each particle is analyzed individually by direct observation and measurement of diffusion events.

This particle-by-particle methodology produces high resolution results for particle size distribution and concentration, while visual validation provides additional data confidence. Both particle size and concentration are measured, while a fluorescence mode provides differentiation of labeled or naturally fluorescing particles.

NTA 3.0 features automatic, integrated hardware detection and communication for all the systems in the NanoSight range. Compared with previous versions it generates fewer files per experiment and results are displayed on clear, concise spreadsheets. Particle size distributions are shown as histograms for easy interpretation.

NanoSight NTA systems are part of Malvern’s expanding portfolio for characterization at the nanoscale. By updating software for greater ease of use and more efficient testing, NanoSight NTA users can be sure of getting the best possible performance from their system. Visit the Malvern website for details or to download:

• NanoSight NS300 www.malvern.com/ns300sw
• NanoSight LM10 www.malvern.com/lm10sw
• NanoSight NS500 www.malvern.com/ns500sw


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!